Simara Artico

Suggest Changes
Learn More
BACKGROUND More than 50% of patients infected with chronic hepatitis C virus (HCV) do not respond to treatment with conventional interferon (IFN) combined with ribavirin (RBV). The aim of our study(More)
  • 1